Healthcare in India has always posed big questions around accessibility and affordability for most of its population. 70% of hospital infrastructure is limited to top 20 cities as there is a great disparity between urban & rural areas. The availability of qualified doctors, nurses and hospital beds per thousand population are 0.7, 1.3 and 1.3 respectively as against 1, 2.5 and 3.5 recommended by WHO. Despite this huge unmet demand and headroom for growth, the threefold jump forecasts to $372B by 2022 seems doubtful considering the current slowdown.

India only spends 4.7% of GDP on healthcare cumulatively with just 1.4% coming from public sector which is lowest in the world. With growing incidence of lifestyle diseases, rising healthcare delivery costs, growing health insurance penetration, there is a need to find affordable and transparent delivery solutions. Technological advancements and government initiatives will play a key role in driving healthcare market in India.

Healthcare industry has typically lagged other sectors when it comes to technology deployment, however this is fast changing. There is a fundamental shift from ‘volume of care’ to ‘value of care’ with the evolution in disruptive digital technologies that promises to address the gaps in the Indian healthcare system. Burdened with margin pressures due to price control and cost escalations, several players are actively using technology to improve productivity as well as quality on outcomes.

Further, the digital wave has empowered patients and created a new breed of demanding consumer, thus forcing healthcare providers and insurance companies to move from a ‘provider and health system’ driven model to one that’s more ‘customer centric’.

As health delivery organizations begin to focus efforts into this new and expanded care continuum, investment opportunities related to tech embedment and product design are expected to drive new investments. However, despite the multiple disruptive solutions and innovations, very few models have been able to scale up successfully.

According to VCCEdge, the sector has consistently attracted $1-2 billion of private investment and $3-5 billion of M&As over the last several years.

• By 2020, India is expected to rank amongst the top 3 healthcare markets in terms of incremental growth
• By 2020, the healthcare information technology market is expected to grow 1.5 times from current $ 1 bn
• By 2022, the diagnostics market is expected to grow at a CAGR of 20.4% to reach $ 32 bn from $ 5 bn in 2012

To discuss the business opportunity and the emerging challenges, VCCircle is organising its next edition of Healthcare Investment Summit on October 11 in Mumbai.


October 11, 2019 | Mumbai
08:15 am onwards Registration & Networking

Venue: Pre-Function Area

09:20 am – 09:30 am Opening Address
9:30 am - 9:40 am Welcome Address
09:40 am – 10:00 am Keynote



10:00 am – 10:40 am Panel Discussion I: The demanding new age patient & care continuum

The new digital health is focussed on four key elements including disruption, integration, “engagement and trust”. Digital is empowering patients to play a more active role in their own care and making processes more efficient for providers. Traditional delivery processes today, face the risk of being disrupted. How are healthcare providers fulfilling the demands of the new age patient? 

Moving health services outside of the hospital and towards patient presence – in other words, enabling a digitalized care continuum will be eminent to combat tech enabled and dynamically disruptive demand drivers. What are the new practices that healthcare providers are adopting?

10:40 am – 11:00 am Lightning Talks

10:40 am – 10:50 am
The Decade of Data: Healthcare beyond 2020

10:50 am – 11:00 am
Health-tech- what does analytics tell us about customer behaviour

11:00 am – 11:40 am Panel Discussion II: Road to digital success in pharma

Pharmaceutical companies have made significant progress on their journey towards digital transformation, despite regulatory restrictions. Digital interventions have helped enhance engagement with doctors, thus transforming historical marketing practices. Further, online pharmacies are empowering customers with better prices and options. How are these pharma stakeholders (Pharma companies, e-pharmacies, hospital purchase, etc) working together to enhance customer & doctor engagement, and make the supply chain more efficient?

11:40 am – 12:10 pm Networking over Tea/Coffee

Venue: Pre-Function Area

12:10 pm – 01:00 pm Mashup

12:10 am – 12:20 am
Short keynote on How is diagnostics industry evolving? 

Followed by 

12:20 am – 13:00 am 
Panel Discussion III on Driving efficiencies in diagnostics business?
With the spectre of Essential Diagnostics List and price caps looming over diagnostics industry, margins may come under pressure. What are the ways pathology chains can leverage technology to drive more efficiencies? How can diagnostic companies, doctors and hospitals work together to provide seamless experience to patients?

01:00 pm - 02:00 pm Networking Lunch

Venue: Pre-Function Area

02:00 pm - 02:30 pm Panel Discussion IV: Regional chains’ national claim

Large corporate hospital chains have seen a string of consolidation moves and eyes are now on the regional champions. Can the regional chains hold their nerves to expand outside their comfort zones? Would the larger national chains see acquisition of smaller hospital groups as the next growth driver? How do the two sets plan to bridge the rising trust deficit of patients?

02:30 pm - 03:10 pm Panel Discussion 5: Health insurance disruptors

While discretionary spending is growing rapidly, the willingness to pay for healthcare hasn’t really gone up. Changing payor mix from individuals to institutional payors, will have huge implications for healthcare spends in the future. 

Technology is playing a key role in integrating the ecosystem of Payor (insurance companies, government for Ayushman Bharat), administrators (Insurance companies, TPA), providers (hospitals, diagnostics). Further, several tech. developments like remote health, m-health, wearables, big-data are being deployed to improve outcomes and reign in efficiencies.  

How do we shift the mindset towards healthcare in an ‘out of pocket’ paying market? How should insurance players, TPAs and hospital operators work in tandem in times to come? What will it take to create a seamlessly connected ecosystem?

03:10 pm - 03:30 pm Networking over Tea/Coffee

Venue: Pre-Function Area

03:30 pm - 04:30 pm Start-up Exchange: HealthTech. LIVE

A curated platform that brings together a set of handpicked innovative healthcare start-ups making an elevator pitch to select jury of angel investors & VCs.

Apply Now

04:30 pm Closing Remarks and End of Conference


Umang Vohra

Managing Director & Global CEO, Cipla

Umang Vohra has been Managing Director and Global Chief Executive Officer (MD & GCEO) of Cipla since September 2016. Umang joined Cipla in October 2015 as its Global Chief Financial Officer, and from January 2016 to August 2016 was Cipla’s Global Chief Operating Officer.

After gaining degrees in engineering, marketing and finance, Umang was associated with companies such as Eicher Motors and PepsiCo. Prior to joining Cipla, Umang was Head of the North America business for Dr. Reddy’s Laboratories. Through his previous roles in India and the USA, he has built a distinguished career spanning almost two decades with deep understanding and experience in various aspects of the global pharmaceutical business.

Under Umang’s leadership, Cipla has built strong momentum in its home markets, augmented its capability, strengthened its core, and shown significant improvement in its operating margin and profitability. At the helm of the Management Council of Cipla, Umang’s big-picture agenda is to define and execute Cipla’s strategic growth roadmap and geographical footprint, identify the next levers of growth, invest in innovation for the future, and build the right organisation. Recognised as an action-oriented industry leader, Umang is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to shaping the healthcare ecosystem and making a difference to the lives of patients.

Ashish Mehrotra

MD & CEO, Max Bupa Health Insurance

Ashish Mehrotra is the Managing Director and Chief Executive Officer (MD&CEO) of Max Bupa Health Insurance. Ashish joined Max Bupa in 2015 and has been leading the brand through various technological innovations to improve product experience and introduce new features in the products to make it more comprehensive in order to help customer’s live healthier, more successful lives. Ashish has nearly three decades of extensive experience in banking and insurance and has been with Max Bupa Health Insurance for the last 4 years.

At Max Bupa, Ashish is responsible for fortifying its portfolio and creating long-term value in a high potential health insurance market. Under Ashish’s leadership, Max Bupa has been building digital platforms to be able to ‘attract’, ‘connect’, ‘engage’, ‘fulfil’ and ‘deepen’ relationships with its customers. Under Ashish’s able guidance, Max Bupa became the first company to build digital platforms, and introduced several digital initiatives in order to improve customer experience at various touch points.

In the banking sector Ashish’s last role was of Managing Director and Head for the Retail division of Citibank in India. In his previous assignment at Citibank, Ashish played a pivotal role in enabling the bank to gain a leadership position in the wealth management business in India. Ashish started his career with Citibank and led several key portfolios in the company including Consumer Assets Head, Business Banking Head and Head for Mortgage Business. Under his leadership, Citibank entered into several productive strategic partnerships to complete the insurance product strategy and digitization of sales processes. He also reengineered ‘Citi at Work’ and emerging affluent segment businesses to attain higher profitability and operating efficiency. Under his leadership, Citibank was awarded the Best Retail Foreign Bank by Dun & Bradstreet in 2013 and 2014. He also led the creation of a unique distribution architecture for consumer banking that was adapted by Asian and Middle East and recognized by ‘The Asian Banker’.

Under Ashish’s tutelage, Max Bupa won various industry awards with one being the recently won and very coveted ET Best Brand Award in 2019. Max Bupa also won the Superbrands Award 2018 under Ashish’s leadership. Further, Max Bupa also won the ‘Best Innovative Medical Insurer’ award at Business World’s 4th Healthcare Summit and Awards 2017.

Besides, Ashish himself has a lot of accolades to his kitty. He has been awarded CEO of the Year at the Future Leaders Summit and Awards in 2018 and he was also named Most Trusted CEO by WCRC Ideasfest 2018. Ashish was also awarded as India’s Greatest Leader by Asia One Awards in 2017.

Ashish is a frequent speaker at well-known industry forums of the likes of FICCI, CII, ASSOCHAM. He is renowned as the most visible face in the health insurance industry.

Ashish holds a bachelor’s degree in business management and an MBA.

Rohit MA

Co-founder and Managing Director, Cloudnine Group of Hospitals

Rohit M A is the Cofounder and Managing Director of Cloudnine Group of Hospitals - India’s leading chain of maternity, women and child care service hospitals. Rohit has played a crucial role in the establishment and growth of the company and expanded operations from a single hospital in South Bangalore to other locations in Bangalore and now a multicity-chain across Chennai, Gurgaon, Mumbai, Pune, Navi Mumbai, Chandigarh, Delhi with more than 18 units and in the pursuit to setup 10 more units in the coming years.

As Managing Director, Rohit currently oversees and is actively involved in several core areas of Cloudnine including strategy, digital revolution, public relations, employee engagement and with critical focus on expansion of presence and development of new business models for the company. He has also led and managed the entire gambit of professionalizing the company and attracting top talents who form the core team of Cloudnine and also been responsible for leading the entire journey and stake holder management of private equity investors and has attracted investments of over 100 million dollars through marquee investors, in the likes of Matrix Partners, Sequoia Capital and TrueNorth (previously IVFA) having invested in to the company.

Tapan Singhel

MD and CEO, Bajaj Allianz General Insurance

Tapan Singhel has a rich experience in the insurance industry of more than 25 years and has been heading Bajaj Allianz General Insurance for 7 years. He has won numerous accolades, to name a few, ‘Personality of the Year’ at the India Insurance Summit & Awards 2019, 22nd Asia Insurance Industry Awards 2018 and Indian Insurance Summit 2017. He was featured as ‘LinkedIn Top Voice in India’ in 2018 and has been recognized as the ‘Most Promising Business Leader’ of Asia at The Economic Times Global Business Summit 2018.

Tapan has also been conferred with the ‘Most Trusted CEO’ Award by WCRC second time in a row in 2018 and won ‘CEO of the Year’ at the prestigious 3rd Annual Insurance India Summit & Awards 2018 and Insurance Asia Awards & Best Admired Leader by White Page International 2016. In his tenure thus far, the company has received AON Best Employer Award in 2016 & 2018 and has been recognised amongst the top 52 companies at India’s Best Companies to Work for 2018 by the coveted Great Places To Work Institute India.

Under his leadership, the company has emerged as the most profitable private general insurer in the country ensuring growth, profitability and customer centricity. While industry has incurred a cumulative underwriting loss of Rs. 72,000 crore in the past 6 years, Bajaj Allianz General Insurance has made a cumulative underwriting profit of Rs. 310 crore under Tapan’s able leadership. Since he took over, the company has expanded its footprint in over 1000 new markets through its “phygital presence” boosting its revenues at a CAGR of 21% and profits at a CAGR of 49%.

Customer obsession and passion to do good for the people is what drives Tapan and his success in the industry. A scientist by education, but insurer at heart he works towards making difference in the lives of people in whatever little way he can. His belief is to live in the moment and cherish it. Tapan has not only transformed the company, but has also been a trendsetter in the insurance industry by always taking the first leap towards innovating to enhance the customer service standards. He has made it a habit of being industry first at initiatives that keep taking the insurance industry forward.

By always imbibing the principle of empathy towards customers and employees, he has been instrumental in the organisation being recognised on various forums. To name a few, Domestic General Insurer of the Year – India at Insurance Asia Awards 2019; General Insurance Company of the Year at 4th Annual Insurance Summit & Awards 2019; Digital Insurer of the Year twice at 22nd and 23rd Asia Insurance Industry Awards; Best Motor Insurance Provider of the Year 2019 at Money Today awards; India’s Leading Private General Insurance Company 2019 by Dun & Bradstreet and the Most Iconic Brand of India 2018 by The Economic Times.

Tapan is known for his ‘Communicative Leadership’ style, where he believes in engaging regularly with employees and customers through social media.

LinkedIn: Tapan, has over 600,000 followers on the platform and is very popular among young and aspiring professionals. His profile has been featured for the fourth time in a row in the LinkedIn Power Profiles 2018 India list. Here is the link to his profile: https://www.linkedin.com/in/tapansinghel

Blog: Tapan is an active blogger and through his blog “My Take”, he writes about anything that strikes a chord with him and puts down his thoughts on things that he believes will make a difference to people’s lives and on the lessons one can effectively learn from the street and apply to business impactfully through his hashtag,  #StreetMBA

Twitter: An avid twitterati, Tapan through his Twitter handle @tapansinghel shares insights on varied subjects, interacts with the customers and addresses customer grievances personally on the platform.

Gaurav Agarwal

Co-founder, 1mg

Gaurav is the co-founder of 1mg, India's #1 Health platform. With over 18 million app downloads, and 160 million monthly Page Views, 1mg is the favorite app for health consumers across the country. Gaurav was born and raised in Kanpur.

He is a Computer Science graduate from Indian Institute of Technology-Delhi (IIT-D). Prior to 1mg, Gaurav was the Business Head at Zynga for its globally bestselling online social gaming business, Farmville.

Praneet Singh

Partner, True North

Praneet joined True North in Oct 2017 and is based in the Mumbai office, where he works closely to build and manage True North portfolio companies in the healthcare space. With over 26 years of experience in the emerging markets, Praneet brings expertise in general management, leadership development, marketing, investing and consulting, with a specific focus on the healthcare and consumer industries. He has worked in diverse markets globally - in India, Southeast Asia, Latin America and the US.

Prior to joining True North, he was with Siguler Guff and Company, building and managing their portfolio of private equity investments in India and Southeast Asia. Before that, he spent five years as the CEO of Piramal Healthcare's India pharmaceutical business, growing it more than three-fold during that period. He has also done long stints as a consultant with McKinsey and Company, focusing on operations and marketing strategy, and as a brand manager with Procter & Gamble. He holds an MBA degree from IIM Calcutta and a bachelor's degree in Mechanical Engineering from IIT Delhi.

HealthTech.LIVE Jury

Prerna Bhutani

Partner, India Quotient

Dr. Ramesh Byrapaneni

MD, Endiya Partners

Dr. Ramesh Byrapaneni, MD, Endiya Partners, is a cardiologist who turned into a venture capitalist, to be a part of the healthcare innovation story. At Endiya, Dr. Ramesh has led our investments in Healthtech companies- SigTuple, ekincare and cure.fit.

Prior to Endiya, at Ventureast, he invested in companies like OneBreath and SmartRx . Dr. Ramesh is also an angel investor with Nephroplus, India’s largest chain of dialysis clinics. Earlier, Dr. Ramesh was Chief of Cardiology and Founder of Medwin Hospital. He is also the Founding Director of Hyderabad Angels and has been President of TiE Hyderabad for four years.



  • *Offered Price +18% GST
  • Total no. of Seats

    Individual Ticket

  • INR 13,000
  • 1

    Gold Package

  • INR 36,000
  • 3

    Diamond Package

  • INR 55,000
  • 5

    Platinum Package

  • INR 70,000
  • 7

For any query, please reach us at register@vccircle.com, +91-9560888566 / +91-120-4171111

Cancellation Policy:

There is no cash refund in case you cancel the registration from your end. We will issue a credit note for an equivalent amount which you can adjust/utilise against any of our future events (under the validity period) if the registration is cancelled at least 3 days before the event, post which NO credit note will be issued. Company reserves the right to amend content, expert, policy, venue & date(s) of the conference. Delegates will be refunded the registration fee in full in case the conference gets cancelled from our end.

Substitution Policy:

Substitutions within a company are permitted through the conference date. Shared registrations are not permitted under any circumstances